Clinical trials
ANXIETY DISORDERS (or Anxiety and Phobic Neuroses) clinical trials
Below are recruiting anxiety disorders (or anxiety and phobic neuroses) clinical trials, each written for real people, not researchers. We’re tracking 927 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06843044RecruitingPhase 4
Testing Ranquilon for anxiety from stress or exhaustion
This study tests a new medication called Ranquilon to see how well it treats anxiety in people with neurasthenia or adjustment disorders. Participants will take the study drug for about 4 weeks, and doctors will check their anxiety and fatigue levels.
Engel'sAges 18–70 - NCT07262801Recruiting
Mindfulness for anxiety in new moms
This study tests whether a mindfulness program can help new mothers or birthing parents manage anxiety. It looks at how the program affects your mind and body during the first year after childbirth.
Hamilton, OntarioAges 18 years+ - NCT00397111Recruiting
MRI brain-scanning study of mood and anxiety in adults
This study uses brain MRI scans and mental tasks to better understand mood and anxiety problems. It may help researchers develop improved MRI methods for studying depression and healthy brain function.
Bethesda, MarylandAges 18–65 - NCT07617467Recruiting
Group therapy for emotional distress in young people
This trial tests whether group-based therapy (Acceptance and Commitment Therapy, or ACT) can help young people manage anxiety, depression, and stress. The therapy teaches skills to accept difficult feelings while living according to your values.
Arendal, AgderAges 16–25 - NCT07590115Enrolling by invitation
Behavioral Patterns and Treatment Success in Substance Use Recovery
This study looks at how behavioral patterns change during residential treatment for substance use disorder. Researchers will track your progress over several weeks to understand what helps people succeed in recovery.
Potrerillos, JaliscoAges 18–60 - NCT07363980Enrolling by invitation
Heart CT Study for Rheumatoid Arthritis Patients
This study uses a special heart CT scan to look for early signs of heart disease in people with rheumatoid arthritis. It may help find problems before symptoms start.
AarhusAges 50–75 - NCT06804525Recruiting
Adapting a mental health survey in Hong Kong
This study adapts a mental health survey for Hong Kong adults. It is open to adults aged 25 and older who live in randomly selected households and can speak Chinese or English.
Hong KongAges 25 years+ - NCT06792175Enrolling by invitation
Using speech to detect mental health conditions
This study uses a computer program to listen to your speech and see if it can help detect mental health or neurodevelopmental conditions. It may help find new ways to diagnose conditions like ADHD, anxiety, depression, and others earlier.
Brookline, MassachusettsAges 13–60 - NCT05712057Recruiting
Brain stimulation vs therapy for emotion regulation problems
This trial compares a type of brain stimulation (rTMS) to therapy to help people better manage strong emotions. You may be eligible if you have ongoing difficulties with emotion control and meet specific mood, anxiety, or related symptom criteria.
Durham, North CarolinaAges 18–55 - NCT07458100Recruiting
Step-by-step digital therapy for emotional disorders
This trial tests a digital stepped-care program for people with emotional disorders like depression, anxiety, OCD, PTSD, or eating disorders. It uses online tools to help manage symptoms, and you may access different levels of support based on your needs.
BeijingAges 18–65 - NCT07759128RecruitingPhase 3
Test of a new anxiety medication for adults with generalized anxiety disorder
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
Jacksonville, FloridaAges 18 years+ - NCT06969170RecruitingPhase 2
Psilocybin oral solution for generalized anxiety disorder trial
This study tests a psilocybin oral solution in adults with generalized anxiety disorder (GAD). It aims to see if the drug is safe, tolerable, and helpful for reducing anxiety symptoms.
Kingston, OntarioAges 18–60 - NCT06526260Recruiting
Very Brief Exposure for Social Anxiety in Teens and Young Adults
This study tests a very short, new type of exposure therapy for social anxiety in teens and young adults. Participants will also have a brain scan (MRI) to see how the therapy affects the brain.
Los Angeles, CaliforniaAges 16–22 - NCT04221997RecruitingPhase 4
Sertraline study for anxious children and teens
This trial tests whether sertraline (an anti-anxiety medicine) helps children and teens with generalized, separation, and/or social anxiety disorders. It also includes healthy children/teens for comparison so researchers can better understand safety and symptoms over time.
Cincinnati, OhioAges 8–17 - NCT04557891Recruiting
Low-intensity ultrasound for generalized anxiety disorder
This trial tests a non-drug brain treatment using low-intensity focused ultrasound to reduce symptoms of generalized anxiety disorder (GAD). It may help if your anxiety has been moderate to severe and you’ve already tried standard medications without enough relief.
Los Angeles, CaliforniaAges 18–65 - NCT04663724Recruiting
Computer-based therapy for social anxiety
This trial tests a computer-based treatment to help people with social anxiety (fear or avoidance of social situations). If you qualify, you may receive structured online therapy designed to reduce social anxiety symptoms.
New York, New YorkAges 18–60 - NCT05466851Recruiting
Study testing anxiety and depression biology and therapy markers
This study looks at “biopsychosocial markers” (biological, psychological, and social signs) in people with major depression and/or anxiety. It aims to understand what changes with treatment and how those changes connect to symptoms like anxiety and depression.
New York, New YorkAges 18–65 - NCT05772104RecruitingPhase 3
Test a Chinese herbal capsule for generalized anxiety
This Phase 3 trial studies Shugan Jieyu Capsule to treat generalized anxiety disorder (GAD). It aims to see if it can reduce anxiety symptoms in people who fit specific anxiety severity and traditional diagnosis criteria.
BeijingAges 18–65 - NCT05843695Recruiting
Therapy study for PTSD and anxiety in veterans
This trial tests a psychotherapy approach to help veterans and service members who have PTSD and/or anxiety disorders. You may be randomly assigned to different therapy conditions, and the study aims to improve quality of life and reduce anxiety and PTSD symptoms.
Houston, TexasAges 18 years+ - NCT05863520Recruiting
Two school programs to help anxious autistic students
This study compares two school-based programs to reduce anxiety in autistic students ages 8–14. You may be able to help test which approach works better when delivered by trained school staff with caregiver involvement.
Aurora, ColoradoAges 7–15 - NCT06066983Recruiting
Treating anxiety in children with autism (DINO RCT)
This study tests a therapy to help young children with autism who also have anxiety. The goal is to reduce anxious behaviors and improve daily life.
Baltimore, MarylandAges 4–6 - NCT06218030RecruitingPhase 4
L-methylfolate for treatment-resistant anxiety
This study tests whether adding L-methylfolate (a form of vitamin B9) to your current antidepressant can help with generalized anxiety disorder that has not responded to other treatments. It is for adults who are already on a stable dose of an SSRI or SNRI medication.
Kingston, OntarioAges 18–65 - NCT06278909Recruiting
Nerve stimulation for stubborn anxiety
This study tests a new, non-invasive treatment using mild electrical stimulation on a nerve in your face (trigeminal nerve) to help with anxiety that hasn't improved with other treatments. It aims to see if this approach is safe and helpful for people with generalized anxiety disorder who have not responded to standard medications.
Kingston, OntarioAges 18–65 - NCT06480383RecruitingPhase 2
Study of an investigational drug for anxiety
This study tests an investigational medication called ITI-1284 added to your current anxiety treatment. It is for people with generalized anxiety disorder whose symptoms have not improved enough with standard medications.
Chandler, ArizonaAges 18 years+
Hear when a new ANXIETY DISORDERS (or Anxiety and Phobic Neuroses) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for anxiety disorders (or anxiety and phobic neuroses)?
- Yes. Clin2 currently lists 927 recruiting anxiety disorders (or anxiety and phobic neuroses) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a anxiety disorders (or anxiety and phobic neuroses) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a anxiety disorders (or anxiety and phobic neuroses) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.